Clinical applications of circulating tumor cells in patients with solid tumors
Clinical & Experimental Metastasis · 2024-08 · 41 (4) · 403-411
DOI: 10.1007/s10585-024-10267-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical & Experimental Metastasis, online erschienen am 28.01.2024. Verfasst von Daniel J Smit und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EUROPEAN HORIZON, European Research Council, Universitätsklinikum Hamburg-Eppendorf (UKE).
Abstract (Originalsprache)
The concept of liquid biopsy analysis has been established more than a decade ago. Since the establishment of the term, tremendous advances have been achieved and plenty of methods as well as analytes have been investigated in basic research as well in clinical trials. Liquid biopsy refers to a body fluid-based biopsy that is minimal-invasive, and most importantly, allows dense monitoring of tumor responses by sequential blood sampling. Blood is the most important analyte for liquid biopsy analyses, providing an easily accessible source for a plethora of cells, cell-derived products, free nucleic acids, proteins as well as vesicles. More than 12,000 publications are listed in PubMed as of today including the term liquid biopsy. In this manuscript, we critically review the current implications of liquid biopsy, with special focus on circulating tumor cells, and describe the hurdles that need to be addressed before liquid biopsy can be implemented in clinical standard of care guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
- Fleur Hiege Center for Skin Cancer Research, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
- Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. pantel@uke.de.
- Fleur Hiege Center for Skin Cancer Research, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. pantel@uke.de.
Förderung
- EUROPEAN HORIZON
- European Research Council
- Universitätsklinikum Hamburg-Eppendorf (UKE)
Zitieren
APA
Smit, D. J., Schneegans, S., & Pantel, K. (2024). Clinical applications of circulating tumor cells in patients with solid tumors. Clinical & Experimental Metastasis, 41(4), 403-411. https://doi.org/10.1007/s10585-024-10267-5
Vancouver
Smit DJ, Schneegans S, Pantel K. Clinical applications of circulating tumor cells in patients with solid tumors. Clinical & Experimental Metastasis. 2024;41(4):403-411. doi:10.1007/s10585-024-10267-5
BibTeX
@article{Smit2024,
author = {Smit, Daniel J and Schneegans, Svenja and Pantel, Klaus},
title = {Clinical applications of circulating tumor cells in patients with solid tumors},
journal = {Clinical & Experimental Metastasis},
year = {2024},
volume = {41},
number = {4},
pages = {403--411},
doi = {10.1007/s10585-024-10267-5}
}
EUVIMED